The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
STEROIDAL PURE ANTIOESTROGENS
Abstract
The effects of some novel 7α-alkyl amide analogues of oestradiol on the rat and mouse uterus have been measured. The compound ICI 164,384 [N-n-butyl-N-methyl-11-(3,17β-dihydroxyoestra-1,3,5(10)-trien-7αyl) undecamide] was entirely devoid of oestrogenic activity in the rat and mouse uterus but completely blocked the uterine stimulatory effects of oestradiol and of tamoxifen. Biological activity was confined to 7α-isomers. The affinity of ICI 164,384 for the rat uterus oestrogen receptor (0.19) was substantially greater than that of tamoxifen (0.025 c.f. oestradiol=l). The compound inhibited oestradiol-induced growth of ZR-71-1 cells in a dose-dependent manner in vitro. ICI 164,384 thus has the characteristics of a pure antagonist of oestrogen action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
Nuclear receptors enhance our understanding of transcription regulation
GREEN, S., & CHAMBON, P. (1988) · Trends in Genetics · doi:10.1016/0168-9525(88)90108-4 · Cited by 1,043
Knabbe, C., Lippman, M. E., Wakefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., & Dickson, R. B. (1987) · Cell · doi:10.1016/0092-8674(87)90193-0 · Cited by 975
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
Early Breast Cancer Trialists' Collaborative Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198812293192601 · Cited by 933
The pharmacology and clinical uses of tamoxifen
Furr, B. J. A., & Jordan, V. C. (1984) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(84)90043-3 · Cited by 864
WEBSTER, N. (1988) · Cell · doi:10.1016/0092-8674(88)90552-1 · Cited by 580
A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITY
JORDAN, V. C., COLLINS, M. M., ROWSBY, L., & PRESTWICH, G. (1977) · Journal of Endocrinology · doi:10.1677/joe.0.0750305 · Cited by 506
Welsch, C. W. (1985) · PubMed · Cited by 492
Biochemical pharmacology of antiestrogen action.
Jordan, V. C. (1984) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06650-5 · Cited by 417
Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J., & Berthois, Y. (1987) · PubMed · Cited by 403
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor
Sutherland, R. L., Murphy, L. C., Foo, M. S., Green, M. D., Whybourne, A. M., & Krozowski, Z. S. (1980) · Nature · doi:10.1038/288273a0 · Cited by 362
CONTROLLED TRIAL OF TAMOXIFEN AS SINGLE ADJUVANT AGENT IN MANAGEMENT OF EARLY BREAST CANCER
(1985) · The Lancet · doi:10.1016/s0140-6736(85)92206-8 · Cited by 309
Novel antioestrogens without partial agonist activity
Wakeling, A. E., & Bowler, J. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90014-3 · Cited by 214
Self-citationSutherland, R. L., Green, M. D., Hall, R. E., Reddel, R. R., & Taylor, I. W. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90177-3 · Cited by 209
Vignon, F., Bouton, M.-M., & Rochefort, H. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90819-9 · Cited by 199
Effects of Plasma Estrogen Sulfates in Mammary Cancer Cells*
VIGNON, F., TERQUI, M., WESTLEY, B., DEROCQ, D., & ROCHEFORT, H. (1980) · Endocrinology · doi:10.1210/endo-106-4-1079 · Cited by 178
Groyer, A., Schweizer-Groyer, G., Cadepond, F., Mariller, M., & Baulieu, E.-E. (1987) · Nature · doi:10.1038/328624a0 · Cited by 177
Bardon, S., Vignon, F., Montcourrier, P., & Rochefort, H. (1987) · PubMed · Cited by 173
Karsch, F. J. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002053 · Cited by 170
Receptors bound to antiprogestin form abortive complexes with hormone responsive elements
Guiochon‐Mantel, A., Loosfelt, H., Ragot, T., Bailly, A., Atger, M., Misrahi, M., Perricaudet, M., & Milgröm, E. (1988) · Nature · doi:10.1038/336695a0 · Cited by 161
THE PREVENTION OF BREAST CANCER
Cuzick, J. M., Wang, D. Y., & Bulbrook, R. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90729-4 · Cited by 154
Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice
Black, L. J., & Goode, R. L. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90049-1 · Cited by 134
Reddel, R. R., & Sutherland, R. L. (1984) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(84)90062-2 · Cited by 125
New biospecific adsorbents for the purification of estradiol receptor.
Bucourt, R., Vignau, M., & TORELLI, V. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34385-5 · Cited by 121
Bindal, R. D., Carlson, K. E., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90352-4 · Cited by 115
Wakeling, A. E., Valcaccia, B., Newboult, E., & Green, L. R. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90197-3 · Cited by 109
Self-citationKatzenellenbogen, B. S., MILLER, M. A., Mullick, A., & Sheen, Y. Y. (1985) · Breast Cancer Research and Treatment · doi:10.1007/bf01806018 · Cited by 109
Steroid Hormones: A Practical Approach
(1989) · Tumori Journal · doi:10.1177/030089168907500230 · Cited by 100
May, F. E. B., & Westley, B. R. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47673-9 · Cited by 77
Prolonged retention of estradiol by human breast cancer cells in tissue culture.
Strobl, J. S., & Lippman, M. E. (1979) · PubMed · Cited by 74
The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor
Bardon, S., Vignon, F., Derocq, D., et al. (1984) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(84)90004-2 · Cited by 72
Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens
Wakeling, A. E., & Valcaccia, B. (1983) · Journal of Endocrinology · doi:10.1677/joe.0.0990455 · Cited by 62
Self-citationSutherland, R. L., Watts, C. K. W., & Ruenitz, P. C. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90763-1 · Cited by 48
Nicholson, R. I., Gotting, K. E., Gee, J. M. W., & Walker, K. J. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90081-7 · Cited by 46
McCormack, S. A., & Clark, J. H. (1979) · Science · doi:10.1126/science.432668 · Cited by 44
Weaver, C. A., Springer, P. A., & Karzenellenbogen, B. S. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-10-936 · Cited by 43
Kurl, R. N., & Morris, I. D. (1978) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1978.tb07752.x · Cited by 42
Differential Sensitivity of Estrogen Target Tissues: The Role of the Receptor*
Kelner, K. L., KIRCHICK, H. J., & Peck, E. J. (1982) · Endocrinology · doi:10.1210/endo-111-6-1986 · Cited by 41
Roy, E. J., Maass, C. A., & Wade, G. N. (1977) · Physiology & Behavior · doi:10.1016/0031-9384(77)90105-6 · Cited by 33
Arafah, B. M., Manni, A., & Pearson, O. H. (1980) · Endocrinology · doi:10.1210/endo-107-5-1364 · Cited by 33
Kelly, P. A., Asselin, J., Caron, M. G., Raynaud, J., & Labrie, F. (1977) · PubMed · Cited by 25
Cited by
(1991) · PubMed · Cited by 1,101
Basic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694
Shevde, N. K., Bendixen, A. C., Dienger, K. M., & Pike, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130200197 · Cited by 502
Patel, H. K., & Bihani, T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.012 · Cited by 499
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action
Osborne, C. K., Wakeling, A., & Nicholson, R. I. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601629 · Cited by 414
Self-citation
Metadata
- Authors
- Wakeling, A. E., & Bowler, J.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 1987-03
- Volume
- 112
- Issue
- 3
- Pages
- R7-R10
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2095092592
- Cited by
- 321
- References
- 41
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.